Natural Course and Clinical Outcomes of Patients With Hemorrhagic Moyamoya Disease
- 13 October 2026
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (7)
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathwayBrain, 2023
- Moyamoya disease: diagnosis and interventionsThe Lancet Neurology, 2022
- Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patientsNeurosurgical Review, 2021
- Overlap WeightingJAMA, 2020
- Childhood Moyamoya: Looking Back to the FuturePediatric Neurology, 2019
- Addressing Extreme Propensity Scores via the Overlap WeightsAmerican Journal of Epidemiology, 2018
- Clinical Characteristics and Natural History of Quasi-Moyamoya DiseaseJournal of Stroke and Cerebrovascular Diseases, 2017
- Quality of life and psychological impact in adult patients with hemorrhagic moyamoya disease who received no surgical revascularizationJournal of the Neurological Sciences, 2013
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Moyamoya disease: current concepts and future perspectivesThe Lancet Neurology, 2008